Cargando…

Novel Complement Factor B Gene Mutation Identified in a Kidney Transplant Recipient with a Shiga Toxin-Triggered Episode of Thrombotic Microangiopathy

Patient: Female, 32-year-old Final Diagnosis: Atypical hemolytic uremic syndrome Symptoms: Kidney injury • loss of the graft • microangiopathic hemolytic anemia • thrombocytopenia Medication: — Clinical Procedure: Dialysis • plasma exchange • plasmapharesis Specialty: Nephrology OBJECTIVE: Rare dise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Korzycka, Joanna, Pawłowicz-Szlarska, Ewa, Masajtis-Zagajewska, Anna, Nowicki, Michał
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623542/ https://www.ncbi.nlm.nih.gov/pubmed/36306276 http://dx.doi.org/10.12659/AJCR.936565

Ejemplares similares

Effects of a Structured Physical Activity Program on Serum Adipokines and Markers of Inflammation and Volume Overload in Kidney Transplant Recipients
por: Muras-Szwedziak, Katarzyna, et al.
Publicado: (2019)

‘I hear and I forget. I see and I remember. I do and I understand.’– incorporating high-fidelity medical simulation into the undergraduate nephrology course
por: Pawłowicz, Ewa, et al.
Publicado: (2020)

Secondary Hemophagocytic Lymphohistiocytosis Complicated by a Cavitary Lung Lesion in a Kidney Transplant Recipient
por: Muras-Szwedziak, Katarzyna, et al.
Publicado: (2021)

Effect of atorvastatin on iron metabolism regulation in patients with chronic kidney disease – a randomized double blind crossover study
por: Masajtis-Zagajewska, Anna, et al.
Publicado: (2018)

Complement in Secondary Thrombotic Microangiopathy
por: Palma, Lilian Monteiro Pereira, et al.
Publicado: (2020)

Effect of intravenous iron on endogenous erythropoietin and FGF-23 secretion in patients with chronic kidney disease
por: Muras-Szwedziak, Katarzyna, et al.
Publicado: (2023)

Effects of combined statin and ACE inhibitor therapy on endothelial function and blood pressure in essential hypertension - a randomised double-blind, placebo controlled crossover study
por: Ruszkowski, Piotr, et al.
Publicado: (2019)

Losartan and Eprosartan Induce a Similar Effect on the Acute Rise in Serum Uric Acid Concentration after an Oral Fructose Load in Patients with Metabolic Syndrome
por: Masajtis-Zagajewska, Anna, et al.
Publicado: (2021)

Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2020)

Thrombotic microangiopathies assessment: mind the complement
por: Blasco, Miquel, et al.
Publicado: (2020)

Postsurgical Thrombotic Microangiopathy and Deregulated Complement
por: van Herpt, Thijs T. W., et al.
Publicado: (2022)

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
por: Aigner, Christof, et al.
Publicado: (2019)

Thrombotic microangiopathy triggered by podocytopathy
por: Veríssimo, Rita, et al.
Publicado: (2021)

Complement, thrombotic microangiopathy and disseminated intravascular coagulation
por: Kurosawa, Shinichiro, et al.
Publicado: (2014)

Complement Mediated Endothelial Damage in Thrombotic Microangiopathies
por: Blasco, Miquel, et al.
Publicado: (2022)

Utility of copeptin and standard inflammatory markers in the diagnostics of upper and lower urinary tract infections
por: Masajtis-Zagajewska, Anna, et al.
Publicado: (2015)

Polish medical students facing the pandemic—Assessment of resilience, well-being and burnout in the COVID-19 era
por: Forycka, Joanna, et al.
Publicado: (2022)

Organizational support, training and equipment are key determinants of burnout among dialysis healthcare professionals during the COVID-19 pandemic
por: Pawłowicz-Szlarska, Ewa, et al.
Publicado: (2022)

Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics
por: Gavriilaki, Eleni, et al.
Publicado: (2019)

Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease
por: Chonat, Satheesh, et al.
Publicado: (2020)

Extra-Renal Manifestations of Complement-Mediated Thrombotic Microangiopathies
por: Hofer, Johannes, et al.
Publicado: (2014)

The potential role of complements in cocaine-induced thrombotic microangiopathy
por: Dejman, Adriana, et al.
Publicado: (2018)

Burnout Syndrome among Pediatric Nephrologists—Report on Its Prevalence, Severity, and Predisposing Factors
por: Pawłowicz-Szlarska, Ewa, et al.
Publicado: (2022)

Different Effects of Empagliflozin on Markers of Mineral-Bone Metabolism in Diabetic and Non-Diabetic Patients with Stage 3 Chronic Kidney Disease
por: Masajtis-Zagajewska, Anna, et al.
Publicado: (2021)

Therapeutic Complement Targeting in ANCA-Associated Vasculitides and Thrombotic Microangiopathy
por: Novikov, Pavel, et al.
Publicado: (2016)

The Syndromes of Thrombotic Microangiopathy: A Critical Appraisal on Complement Dysregulation
por: Timmermans, Sjoerd A. M. E. G., et al.
Publicado: (2021)

Peering into the darkness of drug-induced thrombotic microangiopathy: complement, are you in there?
por: Sabulski, Anthony, et al.
Publicado: (2023)

Complement-Mediated Thrombotic Microangiopathy in Pregnancy: An Educational Case Report
por: Bruno, Valentina, et al.
Publicado: (2023)

Pregnancy in Complement-Mediated Thrombotic Microangiopathy: Maternal and Neonatal Outcomes
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2023)

Complement inhibition for the treatment of COVID-19 triggered thrombotic microangiopathy with cardiac failure: a case report
por: Utebay, Didar, et al.
Publicado: (2021)

Thrombotic Microangiopathies
por: Radhi, Mohamed, et al.
Publicado: (2012)

The thrombotic microangiopathies
por: Copelovitch, Lawrence, et al.
Publicado: (2008)

Thrombotic Microangiopathy Associated with Pazopanib in a Kidney Transplant Recipient
por: Kalla, Shabana, et al.
Publicado: (2021)

Complete remission of thrombotic microangiopathy after treatment with eculizumab in a patient with non-Shiga toxin-associated bacterial enteritis: A case report
por: Omura, Taku, et al.
Publicado: (2016)

Complement C5 inhibition reverses bleomycin-induced thrombotic microangiopathy
por: Salhi, Sofiane, et al.
Publicado: (2020)

Complement inhibitor eculizumab in thrombotic microangiopathy: Single‐center case series
por: Vitkauskaitė, Monika, et al.
Publicado: (2022)

P1642: OUTCOMES IN HOSPITALIZED PATIENTS WITH COMPLEMENT MEDIATED THROMBOTIC MICROANGIOPATHY
por: Logothetis, C., et al.
Publicado: (2022)

Acute Pancreatitis: A Rare Cause of Complement-Mediated Thrombotic Microangiopathy
por: Livingston, Jonathan, et al.
Publicado: (2023)

Kidney Transplant Recipients Show Limited Lung Diffusion Capacity but Similar Hydrogen Peroxide Exhalation as Healthy Matched Volunteers: A Pilot Study
por: Nowak, Piotr Jan, et al.
Publicado: (2023)

Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation
por: Acosta-Medina, Aldo A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2t27jfadbu9msd5d8sjs1l2i09